Presentaties 2013

De medewerkers van SHM geven met regelmaat presentaties waarin bevindingen uit onderzoek en publicaties worden gepresenteerd. Een groot gedeelte van de presentaties is Engelstalig. Hieronder vindt u een overzicht van de presentaties in 2013.

Presentations:

  • The HIV epidemic in the Netherlands: an update
    Peter Reiss
    » Download presentation
    » See webcast
  • Towards the Amsterdam Cohort Studies 30th year: the unique story of HIV and its risk groups 
    Maria Prins
    » Download presentation
    » See webcast
  • Ongoing HIV-1 subtype B transmission networks amongst MSM in the Netherlands
    Bezemer, DO, Ratmann, O, Sighem, A van, Hermanides, G, Dutilh, BE, Faria, NR, Hengel, R van den, Gras, L, Duits, A, Reiss, P, Wolf, F de, Fraser, C, the observational cohort ATHENA
    » Download presentation
  • Predictors and correlates of adherence to combination antiretroviral therapy (cART) for chronic HIV infection: a meta analysis.
    Langebeek, N, Gisolf, EH, Reiss, P, Richter, C, Sprangers, MA, Nieuwkerk, PT
    » Download presentation

Posters:

  • Calendar age predicts CD8+ T-cell senescence in long-term treated HIV-infected patients but not in HIV-uninfected controls
    Joerink, M, Wit, FWNM, Maurer, I, Harskamp, AM, Schouten, J, Prins, M, Reiss, P, Leeuwen, EMM van, Kootstra, NA, on behalf of the AGEhIV Study Group.
  • Risk of non-AIDS-defining events amongst HIV-infected patients not yet on antiretroviral therapy 
    Sighem, AI van, Zhang, S, Kesselring, A, Gras, L, Prins, JM, Hassink, E, Kauffmann, R, Richter, C, Wolf, F de, Reiss, P
    » Download poster
  • Ethnicity has diminished as a risk factor for chronic kidney disease in the current HIV treatment era 
    Schoffelen, AF, Kesselring, AM, Lelyveld, SFL van, Reiss, P, Barth, RE, Hoepelman, AIM, on behalf of the ATHENA national observational cohort study.
    » Download poster 
  • Long-term changes in CD4/CD8 ratio in cART treated HIV-1 infected patients
    Gras, L, Brinkman, K, Prins, JM, Reiss, P
  • Risk factors associated with HIV resuppression on 2nd line treatment following 1st line combination antiretroviral therapy (cART) virologic failure
    Bierhoff, M, Gras, LAJ, Reiss, P, ten Kate, RW
    » Download poster
  • Nevirapine Dose Escalation or Immediate Full Dose When Switching from Efavirenz to Nevirapine in HIV-infected Patients in the ATHENA Cohort Study.
    Blonk, MI, Luin, M van, Smit, C, Wit, FWNM, Kappelhoff, BS, Burger, DM
    » Download poster
  • Cascade of HIV Care in the Netherlands from 2002 to 2013. 
    Engelhard, EAN, Smit, C, Sighem, AI van, Reiss, P, Brinkman, K, Geerlings, SE
    » Download poster
  • Increased risk of virological failure with lamivudine compared to emtricitabine in tenofovir and nevirapine containing antiretroviral therapy 
    Rokx C, Fibriani A, van de Vijver DAMC, Schutten M, Verbon A, Rijnders BJA

https://nchiv.org/

Presentations:

  • Association between Age and Long-term CD4 Cell Count Trajectory in HIV-1 Infected Individuals with Sustained Viral Suppression Depends on CD4 Cell Count at Start cART 
    L. Gras, A. Kesselring, S. van Lelyveld, K. Brinkman, J.M. Prins, P. Reiss, on behalf of the Netherlands ATHENA Observational HIV Cohort
    » Download presentation
    » See webcast
  • Greater Arterial Stiffness in middle-aged HIV-positive men on cART may be Explained by an Increased Prevalence of Hypertension, Smoking and Systemic Inflammation
    K.W. Kooij, F. Wit, J. Schouten, M. van der Valk, N. Kootstra, I. Stolte, M. Prins, B.-J. van den Born, P. Reiss, on behalf of the agEhIV Cohort www.multiwebcast.com/eacs/2013/14th/39193/luuk.gras.association.between.age.and.long-term.cd4.cell.count.trajectory.in.htmlStudy group
    » See webcast 
  • An Updated Prediction Model of the Global Risk of Cardiovascular Disease in HIV-positive Persons; The Datacollection on Adverse Effects of Anti-HIV Drugs (D:A:D) Study 
    N. Friis-Møller, L. Ryom, C. Smith, R. Weber, P. Reiss, F. Dabis, S. De Wit, A. d'Arminio Monforte, O. Kirk, E. Fontas, C. Sabin, A. Phillips, J.D. Lundgren, M. Law, D:A:D Study Group
    » See webcast
  • Prevalence of Detected Drug Resistance across Different Regions of Europe: Data from EuroSIDA 1997-2012 
    A. Schultze, A.N. Phillips, R. Paredes, M. Battegay, J. Rockstroh, L. Machala, J. Tomazic, O. Kirk, J.D. Lundgren, A. Cozzi-Lepri, EuroSIDA in EuroCOORD
    » See webcast
  • Long-term Response to Combination Antiretroviral Therapy in HIV-infected Children in the Netherlands Registered from 1996-2012
    S. Cohen, C. Smit, A.M.C. van Rossum, P.L.A. Fraaij, T.F.W. Wolfs, S.P.M. Geelen, E.H. Schölvinck, A. Warris, H.J. Scherpbier, D. Pajkrt, Dutch Paediatric HIV Study Group
    » See webcast  
  • Vitamin D Level in HIV-infected Persons: Prognostic Value for All-cause Death, and Association with Inflammatory Markers, Results from the EuroSIDA Cohort Study
    J.P. Viard, L. Shepherd, J.C. Souberbielle, J.P. Bastard, S. Fellahi, J. Capeau, J. Reekie, P. Reiss, O. Kirk, J. Lundgren, A. Mocroft, EuroSIDA in EuroCOORD
    » See webcast  
  • Reduced Bone Mineral Density (BMD) is Largely Explained by Lower Body Weight in HIV-positive Individuals and More Pronounced in Younger Men Having Sex with Men (MSM), Regardless of HIV-status
    K.W. Kooij, F.W. Wit, P.H. Bisschop, J. Schouten, I. Stolte, M. Prins, M. van der Valk, B.L. van Eck-Smit, P. Lips, P. Reiss, on behalf of the AGEhIV Cohort Study Group
    » See webcast  
  • The Spectrum of Clinical Disease in HIV-positive Persons and Relationship with Markers of Deteriorating Renal Function
    A. Mocroft, L. Ryom, J. Begovac, A. D'Arminio Monforte, A. Vassilenko, J. Gatell, E. Florence, V. Ormaasen, O. Kirk, J. Lundgren, EuroSIDA in EuroCOORD
    » See webcast
  • Response to Combination Antiretroviral Treatment in HIV Positive Individuals in Europe: Variation by Educational Level 
    S. Lodi, COHERE in EuroCoord
  • Mortality in Migrants Living with HIV in Western Europe: Differences by Geographical Origin and Gender
    S. Monge, on behalf of COHERE in EuroCoord
    » See webcast   
  • Infection Related and Unrelated Malignancies, HIV and the Aging Population
    L. Shepherd, A. Borges, B. Ledergerber, P. Domingo, J. Rockstroh, B. Knysz, O. Kirk, A. Mocroft, J. Lundgren, EuroSIDA in EuroCOORD
    » See webcast  
  • Cascade of HIV Care in the Netherlands from 2002 to 2013
    E.A.N. Engelhard, C. Smit, A.I. van Sighem, P. Reiss, K. Brinkman, S.E. Geerlings, on behalf of the Q-HIV and the ATHENA National Observational Cohort Study Groups
    » Download presentation
    » See webcast
  • Organisation and Delivery of Healthcare for HIV/TB Coinfected Patients in Europe
    M. Mansfeld, A. Skrahina, A.M. Panteleev, J.M. Miro, I. Zeltina, S. Tetradov, A. Mocroft, A. Grzeszczuk, L. Shepherd, N. Bolokadze, J.D. Lundgren, A. Matteelli, F.A. Post, O. Kirk, D.N. Podlekareva, The TB:HIV Study in EuroCoord
    » See webcast
  • Increased risk of virological failure with lamivudine compared to emtricitabine in tenofovir and nevirapine containing antiretroviral therapy. 
    Rokx C, Fibriani A, van de Vijver DAMC, Schutten M, Verbon A, Rijnders BJA

Posters:

  • Estimation of HIV-infected populations in Europe: a pilot study using data for men who have sex with men in the UK 
    Nakagawa F on behalf of the Stochastic Simulation of Outcomes of People with HIV in Europe (SSOPHIE) project working group in EuroCoord
  • Investigating the causal impact of PI- and NNRTI-containing combination antiretroviral therapy (cART) on the risk of mortality: methodological challenges 
    Smith C, Ford D, Hernan M, Sabin C, Reiss P, de Wit S, d’Arminio Montforte A, Pradier C, Law M, Weber R, Bruyand M, Fontas E, El Sadr W, Philips A, Ryom L, Lundgren J, D:A:D Study
  • A survey of ATRIPLA use in clinical practice among treatment-naïve HIV-positive patients in Europe 
    Kirk O, Reiss P, Rakhmanova A, Benhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Mocroft A, EuroSIDA in EuroCoord
  • Estimation of percentage of HIV-infected people with future limited antiretroviral drug options in a closed observational setting over the period 2007-2011 and beyond 
    Cozzi-Lepri A, Phillips AN, Paredes R, Jablonowska E, Florence E, Pedersen C, Staub T, Ledergerber B, Kirk O, Mocroft A, Lundgren J, EuroSIDA in EuroCoord
  • Development of thrombocytopenia (TCP) and AIDS (ADEs) and serious Non-AIDS (NADEs) Events in Europe 
    Borges AH, Lundgren JD, Kirk O, Ridolfo A, Katlama C, Antunes F, Grzeszczuk A, Blaxhult A, Mitsura VM, Mocroft A on behalf of EuroSIDA in EuroCOORD
  • The development of computer models that predict response to HIV therapy accurately without a genotype: A potential tool for therapy optimisation in resource-limited settings 
    Revell AD, Streinu-Cercel A, Ene L, Dragovic G, Hamers R, Morrow C, Wood R, Tempelman H, Wensing AM, Reiss P, van Sighem A, Pozniak A, Montaner J, Lane HC, Larder BA, RDI Study Group
  • High on-treatment virologic response rates with boceprevir or telaprevir in naive and pre-treated HIV/ HCV co-infected patients 
    Arends JE, Brinkman K, Richter C, Smit C, Schippers EF, van der Valk M, van de Ende M, de Vries-Sluijs TE, Schinkel J, Reiss P, van der Meer J, Hoepelman AIM

http://www.eacs-conference2013.com/index.php?id=40

  • The effect of antiretroviral penetration into the Central Nervous System on the incidence of AIDS-defining neurological conditions in a prospective observational study 
    Caniglia E.

http://www.intmedpress.com/comorbidities/

  • Higher rates of triple class virologic failure in perinatally HIV-infected teenagers compared to heterosexually infected young adults in the PLATO II study
    Gibb DM, on behalf of the PLATO II Project Team of COHERE.
  • Late HIV diagnosis, late initiation of combination ART and mortality in Europe: variation by educational level
    Lodi S, COHERE in EuroCoord.

http://www.ias2013.org/

  • Use of longitudinal case reporting data for estimation HIV prevalence
    Van Sighem A.
  • SHM: Monitoring of HIV in the Netherlands
    Van Sighem A, Zaheri S, Reiss P.

http://www.who.int/en/

  • Cascade of HIV care
    Van Sighem A.
  • Virale SOA – Surveillance 2012
    Op de Coul E.
  • HIV delay studie – Tijd tot zorg
    Van Veen M.

http://www.rivm.nl/

  • Accurate prediction of response to HIV therapy without a genotype a potential tool for therapy optimisation in resource-limited settings
    Larder BA, Revell AD, Wang D, Hamers R, TempelmanH, Barth R, Wensing AMJ, Morrow C, Wood R, van Sighem A, Reiss P, Nelson M, Emery S, Montaner JM, Lane HC, on behalf of the RDI study group.

http://www.informedhorizons.com/resistance2013/

  • Nevirapine dose escalation or immediate full dose when switching from efavirenz to nevirapine in HIV-infected patients in the ATHENA cohort study (presentation)
    Blonk M, van Luin M, Smit C, Wit F, Kappelhoff B, Burger D

http://www.nvza.nl/thema_s/nederlandse_ziekenhuisfarmaciedagen_2013

  • Transmission dynamics of the worldwide HIV-1 subtype B epidemic regarded from a Caribbean island
    Daniela Bezemer (presenter), Gonneke Hermanides, Nuno Rodrigues Faria, Ard van Sighem, Christophe Fraser, Frank de Wolf, Ashley Duits
    Poster
  • HIV-1 subtype B transmission networks of heterosexually infected patients co-infected with HCV
    Daniela Bezemer (presenter), Colette Smit, Ard van Sighem, Frank de Wolf

http://cme.ucsd.edu/hivdynamics/

  • Pre-exposure prophylaxis versus 'test and treat' amongst men who have sex with men in the Netherlands
    Ard van Sighem (presenter), Rob van den Hengel, Daniela Bezemer, Frank de Wolf
    Presentation

http://www.treatmentaspreventionworkshop.org/conference/2013-treatment-as-prevention-workshop/

  • Nevirapine dose escalation or immediate full dose when switching from efavirenz to nevirapine in HIV-infected patients in the ATHENA cohort study (poster)
    Blonk M, van Luin M, Smit C, Wit F, Kappelhoff B, Burger D

https://www.virology-education.com/event-pages-parent/14th-international-workshop-on/

Presentations

  • Association between Age and Long-Term CD4 Cell Count Trajectory in HIV-1 Infected Individuals with Sustained Viral Suppression Depends on CD4 Cell Count at Start cART
    Luuk Gras (presenter), Anouk Kesselring, Steven van Lelyveld, Jan M. Prins, Frank de Wolf, Peter Reiss
    Presentation
  • Pre-exposure prophylaxis amongst men who have sex with men in the Netherlands
    Ard van Sighem (presenter), Rob van den Hengel, Daniela Bezemer, Frank de Wolf
    Presentation
  • Cumulative viral burden is associated with all-cause, AIDS-related and non-AIDS-related mortality following ART initiation among treatment naïve HIV-1-infected patients
    Sterne J on behalf of ART-CC
  • Association of time-varying adherence to ART on rates of AIDS/death: cross-cohort analysis 
    Turner N on behalf of ART-CC
  • Longitudinal modelling of HCV RNA levels in chronically infected individuals with documented HCV seroconversion intervals 
    Prins M on behalf of Amsterdam Cohort Studies
  • Reduced bone mineral density (BMD) is largely explained by lower body mass index in HIV-positive individuals, and more pronounced in younger MSM, regardless of HIV-status
    Kooij K on behalf of The AGEhIV cohort study
  • Higher rates of triple class virologic failure in perinatally HIV-infected teenagers compared to heterosexually infected young adults in the PLATO II study 
    Rojo Conejo P on behalf of COHERE in EuroCoord

Posters

  • Cardiovascular risk profiles in HIV infection in Europe 
    Schultze A, on behalf of EuroSIDA in EuroCoord
  • Prevalence and impact of transmitted drug resistance on response to antiretroviral therapy in children 
    Wittkop L, on behalf of the EuroCoord-CHAIN Joint Project
  • Risk factors for preterm delivery among HIV-positive pregnant women in a Ukrainian cohort 
    Bagkeris E, on behalf of the European Collaborative Study in EuroCoord
  • Tuberculosis in pediatric ART programs in lower income countries: a global view on diagnostics and screening practices 
    Davies M-A, on behalf of the International Epidemiologic Database to Evaluate AIDS (IeDEA)
  • An individual-based stochastic simulation model of the natural history of HIV infection
    Fumiyo Nakagawa on behalf of the Stochastic Simulation of Outcomes of People with HIV in Europe (SSOPHIE) project working group in EuroCoord. 
  • Response to anti-HCV treatment in HIV-infected patients chronically infected with Hepatitis C.
    Colette Smit, Jan van der Meer, Ineke van der Ende, Joop Arends, Marc van der Valk, Kees Brinkman, Emile Schippers, Frank de Wolf, Martin Schutten, Janke Schinkel, Dorine de Vries-Sluijs, Andy Hoepelman, Clemens Richter.
    Poster
  • The effect of antiretroviral penetration in the Central Nervous System on the incidence of AIDS-defining neurological conditions in a prospective observational study
    Caniglia E, on behalf of the HIV-CAUSAL Collaboration.
  • Immune reconstitution inflammatory syndrome: opportunistic infections and AIDS malignancies in patients initiating combination antiretroviral therapy
    Lodi S, on behalf of the HIV-CAUSAL Collaboration.
  • Differences in high HIV-1 viraemia following acute infection and cumulative burden over 2 years by HIV-1 subtype
    Touloumi G, on behalf of the CASCADE Collaboration in EuroCoord.
  • The effect of boosted lopinavir versus boosted atazanavir-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
    Cain L, on behalf of HIV-CAUSAL Collaboration.
  • Association of CD4 count at start of ART with long term mortality among patients who started ART before 2002
    Mirza S, on behalf of the ART Cohort Collaboration (ART-CC).
  • Short and long term prognostic value of vitamin D for AIDS, non-AIDS defining events and all-cause mortality
    Shepherd L, on behalf of EuroSIDA for EuroCoord
  • Defining self-reported and prescription measures of adherence to ART; multi-cohort analysis
    Ingle S, on behalf of the ART Cohort Collaboration (ART CC).
  • An Evaluation of 10 Elite Controller Definitions Over ART Naïve Follow-up within a Large Seroconverter Cohort Collaboration
    Olson A, on behalf of the CASCADE Collaboration in EuroCoord.
  • Age and CD4 count increase on cART: a look behond the effect of older age on the average CD4 recovery to acquire additional insight on the phenomenon
    Cozzi-Lepri A, on behalf of EuroSIDA in EuroCoord.
  • Temporal trends in prognostic markers of HIV disease progression and transmission
    Pantazis N, on behalf of CASCADE Collaboration in EuroCoord.
  • Modeling the course of the HCV epidemic among HIV-positive MSM in the Netherlands
    Prins M, on behalf of the MOSAIC Study Group.
  • Is response to anti-HCV treatment predictive of mortality in HCV/HIV positive patients?
    Cozzi-Lepri A, on behalf of COHERE in EuroCoord.

http://www.iwhod.org/

 

  • Increased risk of cardiovascular disease with age in men: A comparison of D:A:D with HIV-cardiovascular disease risk equations (presentation)
    Petoumenos K, El-Sadr W, d’Arminio Montforte A, Sabin C, Reiss P, Ryom L, De Wit S, Rickenbach M, Lundgren J, Law M, for D:A:D Study Group 
  • Mortality after starting ART in treatment-naïve adults in 3 continents: collaborative analysis of international epidemiologic databases to evaluate AIDS in Southern Africa and ART Cohort Collaboration cohorts (presentation)
    Boulle A, Schomaker M, May M, Egger M, Sterne J and site investigators from IeDEA-SA and ART-CC Collaborations 
  • Risk of non-AIDS-defining events amongst HIV-infected patients not yet on antiretroviral therapy
    Ard van Sighem (presenter), Anouk Kesselring, Luuk Gras, Jan Prins, Elly Hassink, Robert Kauffmann, Clemens Richter, Peter Reiss, Frank de Wolf
    Poster
  • Contribution of AIDS and Non-AIDS deaths to lower life expectancy of ART-treated HIV+ individuals compared with the general population (poster)
    May M, Mocroft A, Guest J, Crane H, Reiss. P, d’Arminio Monforte, Labarga P, Wasmuth J-C, Ingle S, Hogg R, and ART Cohort Collaboration
  • Effect of HIV-1 subtypes on virological and immunological response to initial cART: A European multicohort study (poster)
    Wittkop L, on behalf of EuroCoord-CHAIN Subtype Project Team
  • Mortality of treated HIV-1+ individuals according to viral subtype in Europe and Canada: ART Cohort Collaboration (poster)
    May M, Gill M, Harrigan R, Klein M, Reiss P, Mocroft A, d’Arminio Montforte A, Zangerle R, Cavassini M, Sterne J, and ART Cohort Collaboration
  • Increased risk of ARV drug discontinuation among patients with high hyaluronic acid, a marker of liver fibrosis (poster)
    Grint D, Peters L, Rockstroh J, Lundgren J, De Wit S, Mitsura V, Kynsz B, Pedersen C, Kirk O, Mocroft A and EuroSIDA
  • Cancer risk and use of protease inhibitor- or NNRTI-based cART; The D:A:D study (poster)
    Bruyand M, Ryom L, Shepherd L, Reiss P, de Wit S, d’Artimio Monforte A, Rickenbach M, Philips A, Lundgren L, Sabin C, and D:A:D Study Group
  • Improvements in short-term mortality following myocardial infarction: The Data Collection on Adverse events of Anti-HIV Drugs study (poster)
    Sabin C, Ryom L, Law M, El-Sadr W, Kirk O, Bruyand M, Reiss P, Pradier C, Ledergerber B, Lundgren J and D:A:D Study Group
  • A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology CollaborationEstimating Equations (poster)
    Mocroft A, Ryom L, Reiss P, Ledergerber B, d’Aminio Monforte A, Gatell J, de Wit S, Beniowski M, Lundgren J, Kirk O and EuroSIDA in EuroCOORD
  • Predictors of advanced chronic kidney disease and end-stage renal disease in HIV+ persons: D:A:D (poster)
    Ryom L, Mocroft A, Kirk O, El-Sadr W, Ross M, Reiss P, De Wit S, Morlat P, Fux C, Lundgren J, and D:A:D Study Group
  • The incidence and risk of AIDS-defining illnesses at current CD4 counts of 500/mm3 or higher (poster)
    Mocroft A and COHERE in EuroCOORD
  • Mean asymptomatic viral load, steady state viral load and CD4 cell count following acute infection as predictors of HIV disease progression (poster)
    Olson A, Touloumi G, Geskus R, Meyer L, Prins M, Chêne G, De Luca A, Costagliola D, and Porter K for CASCADE Collaboration in EuroCOORD
  • Trends and factors associated with virological failure among women conceiving on cART in Western Europe (poster)
    Bailey H, Townsend CL, Cortina Borja M, Thorne C for the European Collaborative Study in EuroCOORD

http://retroconference.org/